Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polystyrene sulfonate and amitriptyline binding interaction study
NL-OMON26934Not yet recruiting
- Sponsor
- Deventer Ziekenhuis
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amitriptyline and sodium polystyrene sulfonate in major depressive disorder (MDD), Neuralgia and hyperkalemia (2 arms), sponsored by Deventer Ziekenhuis. Primary endpoints: Amitriptyline Cmax and Amitriptyline AUC0-8h. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
amitriptylinesodium polystyrene sulfonate
03
Conditions
major depressive disorder (MDD)Neuralgiahyperkalemia
Beyond the preview
Go deeper on NL-OMON26934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26934.